BioRegenx, Inc.
BRGX
$0.01
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.40K | -1.02M | -80.60K | -178.30K | -266.90K |
| Total Depreciation and Amortization | 12.90K | 37.90K | -12.60K | 37.40K | 12.40K |
| Total Amortization of Deferred Charges | -- | -25.00K | 27.00K | -1.20K | 1.50K |
| Total Other Non-Cash Items | -47.00K | 856.70K | 84.90K | 94.40K | 91.30K |
| Change in Net Operating Assets | 87.10K | 217.80K | -90.30K | 50.90K | 199.30K |
| Cash from Operations | 26.60K | 69.60K | -71.60K | 3.20K | 37.70K |
| Capital Expenditure | -- | -3.10K | -6.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -50.00K | -- |
| Cash from Investing | -- | -3.10K | -6.00K | -50.00K | -- |
| Total Debt Issued | 5.80K | 0.00 | 117.50K | 30.00K | -- |
| Total Debt Repaid | -56.00K | -44.10K | -46.70K | -13.20K | -10.40K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -50.20K | -44.10K | 70.80K | 16.80K | -10.40K |
| Foreign Exchange rate Adjustments | -- | 0.00 | 7.20K | -7.20K | -2.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.60K | 22.40K | 500.00 | -37.20K | 25.20K |